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S U M M A R Y
Photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA) is an emerging technique for the
treatment of genital human papillomavirus (HPV)-induced benign and premalignant lesions. We report
herein a case series of anogenital CA successfully treated with ALA-PDT and review the literature
available to date on this topic. Thirteen out of 14 cases of anogenital condylomata acuminata were
successfully treatedwith topical PDT.We conclude that PDT can be considered a highly effective and safe
treatment option for anogenital condylomata acuminata. Also, considering the available literature, the
best results are likely to be achieved with a 16–20% gel formulation of 5-ALA and a red light dose of 100–
150 J/cm2.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Genital condylomata acuminata (CA) are common, sexually-
transmitted lesions, caused most often by the human papilloma-
virus (HPV) types 6 and11. Theyaffect both females andmales and
occur in all regions of the anogenital area. Conventional
treatment, often involving repeated local drug application or
invasive methods, has not been deﬁnitively demonstrated to be
effective in eliminating CA lesions and preventing them from
recurring.1 Moreover, such treatments can be painful, are
associated with a long healing time, and sometimes lead to
bacterial infection.
Photodynamic therapy (PDT)with 5-aminolevulinic acid (ALA)
is an emerging technique for the treatment of genital HPV-
induced benign and premalignant lesions. Results from case
series2–7 and controlled trials8,9 suggest that, compared with
conventional therapies, topical ALA-PDT is an effective, safe, and
well-tolerated treatment for CA, and is associated with a low
recurrence rate.
We report herein a case series of anogenital CA successfully
treatedwith ALA-PDT and review the literature available to date on
this topic.* Corresponding author. Tel.: +1 305 243 6704; fax: +1 305 243 9153.
E-mail address: daniele.torchia@uniﬁ.it (D. Torchia).
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Anogenital mucocutaneous viral CA were diagnosed in 14
patients (seven males, seven females; age range 16–38 years,
average 31.3 years) on the basis of the clinical picture, histological
examination, and/or in situ DNA HPV hybridization. In female
patients lesions involved the vulva (three cases), perianal region,
fork, fornix, and portio; in males the penile shaft (four cases),
suprapubic region, glans penis with foreskin, and urethral meatus
were involved. Eleven patients had not undergone any previous
treatment, while two had been treated with electrocoagulation
and one with imiquimod 5% cream.
Following receipt of signed informed consent, a gel containing
16% 5-ALA was applied topically and covered with a polyethylene
dressing. The same ALA solution was injected intralesionally
through a standard insulin syringe into any large and/or thick
lesions in order to achieve greater bioavailability of ALA. A
transvaginal probe was used for application on internal lesions.
After 3 h, the application sites were irradiated with 120 mJ/cm2/s
of red light with a peak emission at 630 nm (PDT-CLD 100, E.P.E.M.
s.r.l., Italy) to a total dose of 150 J/cm2. For the treatment of
intravaginal disease, vaginal walls were separated by placement of
a translucent plastic bivalve speculum. If deemed necessary,
additional treatment sessions were performed every 15 days.
Follow-up visits were performed after 15 days and at 1, 3, 6, and 12
months.ses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Pre- and post-treatment images of some cases. A: condylomata acuminata (CA) of the vulvar and perivulvar area; B: complete resolution after 1 month. C: single CA
of the inner surface of the left labiusminor (arrow); D: complete resolution after 1month. E: single CA of the penile shaft (arrow); F: complete resolution after 1month. G: CA
of the external urethral meatus; H: complete resolution after 1 month.
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only one treatment session, and in 4 patients after two sessions
(Figure 1). These 13 patients were followed-up for at least 12
months and no relapses were registered. In one case, who
presented a large, ﬂat-plaque CA area involving the auction,
balanopreputial furrow and glans penis, an incomplete resolution
occurred, and the patient was lost to treatment and follow-up after
three sessions. No signiﬁcant side effects were reported, however
there was an intense sensation of burning during and immediately
after exposure to the light.3. Discussion
Our case series shows that a complete response was achieved
in 13 out of 14 cases (92.8%) of anogenital CA treated with one to
two sessions of ALA-PDT. No recurrences were registered and the
treatment was very well tolerated by the patients. These data
conﬁrm those already available from previous studies. As shown
in Table 1, a total of 313 patients with a cure rate of 94.9% and a
recurrence rate of 7.9% (though there were wide differences in
follow-up duration), as well as mild local side effects, have been
Table 1
Data from previous studies on the use of photodynamic therapy with 5-aminolevulinic acid for the treatment of genital condylomata acuminata
Ref. Study
type
No.
cases
M/F Concentration
of 5-ALA gel
Applied
light dose
(J/cm2)
No. PDT
sessions
Response
(No. cases)
No. recurrent
cases (time
after treatment)
Local side
effects
Control Notes on
controls
C P/N
2 CS 7 4/3 20% 50–100 1 4 3 1 (4 w) Pain None
8 URCT 16 0/16 10% 11616 1 10 6 9 (12 m) Burning, stinging,
pain
CO2 laser Overlapping
results
3 CS 25 0/25 3.3 mg/ml 30 1–? 25 0 0 Burning None
4 CS 12 12/0 20% (cream) 70–100 1–2 12 0 2 (2 m) Erythema, swelling None
5 CS 164 108/56 10% 100 1–4 164 0 8 (1–3 m) Burning, stinging,
pain
None
6 CS 9 9/0 20% 37 1–4 3 6 1 (3 w) Pain None
7 CS 1 1/0 20% 50 10 1 0 0 Burning None
9 RCT 65 44/21 20% 100 1–2 65 0 4 (4 m) Burning, stinging,
swelling, erythema,
erosion
CO2 laser Overlapping
results. 100%
rate of side
effects (pain,
erosion, ulcer,
pigmentary
changes)
P CS 14 7/7 16% 150 1–2 13 1 0 Pain None
Total 313 185/128 297 16 25
% 100 59.1/40.9 94.9 5.1 7.9
M/F, male-to-female ratio; 5-ALA, 5-aminolevulinic acid; PDT, photodynamic therapy; C, complete; P/N, partial/none; P, present study; CS, case series/report; URCT,
unrandomized controlled trial; RCT, randomized controlled trial; w, weeks; m, months.
V. Nucci et al. / International Journal of Infectious Diseases 14S (2010) e280–e282e282reported in the literature so far.2–9 Also, two controlled trials, one
unrandomized8 and the other randomized,9 showed that ALA-PDT
achieved similar results to CO2 laser vaporization, the latter
causing a higher frequency of transient and long-term side
effects.9
When considering treatment modalities, lower concentrations
of 5-ALA8 and lower light doses2,3,6,7 resulted in worse outcomes2,8
or the need for more treatment sessions to achieve a complete
resolution of lesions.3,5–7 On the other hand, higher concentrations
of 5-ALA coupledwith higher light doses,4,9 as in our study, showed
optimal results without affecting the frequency and gravity of side
effects. However, it has to be mentioned that at least two studies
achieving worse results included a majority of patients who had
proven refractory to previous treatments,5,6 therefore the treated
populations among the various trials cannot be considered
homogeneous.
We conclude that ALA-PDT can be considered a highly effective
and safe treatment option for anogenital CA. The best results are
likely to be achieved with a 16–20% gel formulation of 5-ALA and a
red light dose of 100–150 J/cm2.
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